XLVS.L vs. SBIO.L
Compare and contrast key facts about Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L).
XLVS.L and SBIO.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XLVS.L is a passively managed fund by Invesco that tracks the performance of the S&P® Select Sector Capped 20% Health Care Index. It was launched on Dec 16, 2009. SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014. Both XLVS.L and SBIO.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XLVS.L vs. SBIO.L - Performance Comparison
Loading graphics...
XLVS.L vs. SBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLVS.L Invesco Health Care S&P US Select Sector UCITS ETF Acc | -4.71% | 14.78% | 2.15% | 1.56% | -2.62% | 27.57% | 12.04% | 20.54% | 4.30% | 21.93% |
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 3.46% | 32.89% | -2.00% | 6.14% | -11.85% | -0.49% | 27.35% | 25.54% | -11.34% | 21.45% |
Returns By Period
In the year-to-date period, XLVS.L achieves a -4.71% return, which is significantly lower than SBIO.L's 3.46% return. Over the past 10 years, XLVS.L has outperformed SBIO.L with an annualized return of 9.53%, while SBIO.L has yielded a comparatively lower 8.04% annualized return.
XLVS.L
- 1D
- 1.78%
- 1M
- -6.39%
- YTD
- -4.71%
- 6M
- 4.80%
- 1Y
- 3.47%
- 3Y*
- 6.07%
- 5Y*
- 6.19%
- 10Y*
- 9.53%
SBIO.L
- 1D
- 2.44%
- 1M
- 0.99%
- YTD
- 3.46%
- 6M
- 18.05%
- 1Y
- 40.72%
- 3Y*
- 13.23%
- 5Y*
- 4.67%
- 10Y*
- 8.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XLVS.L vs. SBIO.L - Expense Ratio Comparison
XLVS.L has a 0.14% expense ratio, which is lower than SBIO.L's 0.40% expense ratio.
Return for Risk
XLVS.L vs. SBIO.L — Risk / Return Rank
XLVS.L
SBIO.L
XLVS.L vs. SBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XLVS.L | SBIO.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.20 | 1.77 | -1.57 |
Sortino ratioReturn per unit of downside risk | 0.40 | 2.38 | -1.99 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.31 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.39 | 3.21 | -2.82 |
Martin ratioReturn relative to average drawdown | 0.83 | 14.30 | -13.46 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XLVS.L | SBIO.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | 1.77 | -1.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.43 | 0.22 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | 0.36 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.27 | +0.37 |
Correlation
The correlation between XLVS.L and SBIO.L is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
XLVS.L vs. SBIO.L - Dividend Comparison
Neither XLVS.L nor SBIO.L has paid dividends to shareholders.
Drawdowns
XLVS.L vs. SBIO.L - Drawdown Comparison
The maximum XLVS.L drawdown since its inception was -26.88%, smaller than the maximum SBIO.L drawdown of -39.44%. Use the drawdown chart below to compare losses from any high point for XLVS.L and SBIO.L.
Loading graphics...
Drawdown Indicators
| XLVS.L | SBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.88% | -39.44% | +12.56% |
Max Drawdown (1Y)Largest decline over 1 year | -10.69% | -14.07% | +3.38% |
Max Drawdown (5Y)Largest decline over 5 years | -17.56% | -38.33% | +20.77% |
Max Drawdown (10Y)Largest decline over 10 years | -26.88% | -38.33% | +11.45% |
Current DrawdownCurrent decline from peak | -7.16% | -2.55% | -4.61% |
Average DrawdownAverage peak-to-trough decline | -4.85% | -17.03% | +12.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.95% | 2.85% | +2.10% |
Volatility
XLVS.L vs. SBIO.L - Volatility Comparison
The current volatility for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) is 4.65%, while Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a volatility of 7.64%. This indicates that XLVS.L experiences smaller price fluctuations and is considered to be less risky than SBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XLVS.L | SBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.65% | 7.64% | -2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 9.65% | 14.10% | -4.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.31% | 22.31% | -5.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.54% | 21.26% | -6.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.44% | 22.28% | -6.84% |